Empowering patients through data
Driving a new era of diagnostics and precision treatment to improve the lives of patients.

Pathology
Artificial
Intelligence
Guidance
Engine
Mission
We’re on a mission to use the incredible power of tissue-based AI to develop and deliver globally, a new generation of digital diagnostics and predictive tests, empowering pathologists and transforming oncology.
About Paige
Using AI to inspire a new future for pathology
Led by a team of experts in the fields of life sciences, oncology, pathology, technology, machine learning, and healthcare, Paige strives to transform cancer diagnostics. We make it possible not only to provide additional information from digital slides to help pathologists perform their diagnostic work efficiently and confidently, but also to go beyond by extracting novel insights from digital slides that can’t be seen by the naked eye. These unique tissue signatures have the potential to help guide treatment decisions and enable the development of novel biomarkers from tissues for diagnostic, pharmaceutical and life sciences companies.


How we support our mission
Esteemed leadership
- Led by a team of experts in pathology, machine learning and healthcare
Improving traditional pathology
- Software that provides additional information on every slide
- Helps Pathologists work efficiently and confidently
Paving the future of pathology
- Advanced software to extract new information from pathology slides for additional information to create the most informed and personalized patient treatment workflows possible
Commitment to making an impact
- Empowering pathologists and transforming oncology
Timeline of Paige
use in Europe (CE-Mark)
Meet our founders
David S. Klimstra, MD
Founder, Chief Scientist
“At Memorial Sloan Kettering, we began the process of digitizing pathology slides in 2008, using the resulting digital images to develop a research program in computation pathology. These resulting AI algorithms demonstrated the potential to transform diagnosis and to develop digital prognostic and predictive biomarkers. We founded Paige in order to bring these research tools to clinical use— to ultimately help transform the practice of pathology.”
Thomas Fuchs, Dr. Sc.
Founder, Chief Scientist
“This is a critical time for Pathology, as pathologists are carrying a heavier workload than ever before. Paige was founded to help address their needs through cutting-edge technologies. Paige represents the future of computational pathology and we believe in empowering pathologists with additional insights from rich images, so they can make more effective, confident diagnoses.”